Browse By: Country ι Category ι Latest Reports ι Tag

Plant Growth Regulators Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2012 - 2018

Pages » 60
Published By » Transparency
Price » $4795
In stock
View Report Details
Description

Plant growth regulators, also known as plant hormones are chemicals occurring in low concentrations, which promote plant growth by increasing the supply or availability of primary nutrients to the plant. Various plant growth regulators such as cytokinins, auxins, and mepiquat chloride are used in certain agriculture and pharmaceutical applications. The report on plant growth regulators provides a detailed analysis and forecast of the market on a global as well as regional level. On a global level, the market has been segmented on the basis of revenue (USD million) for a period ranging from 2013 to 2019. For an in-depth understanding of the market on the regional level, the demand has been... Click here for more details


Manufacturing of Biologics - Increasing Demand for Monoclonal Antibodies and Recombinant Proteins Drives Increases in Capacities and Innovative Production Technologies
GBI Research's report, “Manufacturing of Biologics - Increasing Demand for Monoclonal Antibodies and Recombinant Proteins Drives Increases in Capacities and Innovative Production Technologies”, provides the key data and analyzes the major challenges and drivers for the biomanufac
Published Date: Sep 2010
Price: $3500
Biomarkers in Cancer Research - High Unmet Need in Cervical Cancer and Lung Cancer to Drive Growth
GBI Research, the leading business intelligence provider, has released its latest report, “Biomarkers in Cancer Research - High Unmet Need in Cervical Cancer and Lung Cancer to Drive Growth” that provides key data, information and analysis of the major trends and issues affecti
Published Date: Sep 2010
Price: $3500
Nanotechnology in Drug Delivery - Technological Improvements and Novel Approaches to Fulfill High Potential
GBI Research, the leading business intelligence provider, has released its latest report, “Nanotechnology in Drug Delivery - Technological Improvements and Novel Approaches to Fulfill High Potential” that provides key data, information and analysis of the major trends and issues in
Published Date: Dec 2010
Price: $3500
Biotechnology Industry 2010 Yearbook - Top Biologics, Biosimilars, Licensing and Financing, Mergers and Acquisitions
GBI Research, the leading business intelligence provider, has released its latest report, “Biotechnology Industry 2010 Yearbook - Top Biologics, Biosimilars, Licensing and Financing, Mergers and Acquisitions” that provides key data, information and analysis of the major trends and
Published Date: Dec 2010
Price: $3500
Early Stage Drug Discovery in Disease Segments - Innovation Focuses on Stem Cell Therapies and Gene Therapies
GBI Researchs new report, Early Stage Drug Development in Disease Segments Innovation Focuses on Stem Cell Therapies and Gene Therapies, provides an in-depth analysis of the unmet needs, drivers and barriers that affect the global Central Nervous System Disorders (CNS), Metabolic Disorders, Immu
Published Date: Feb 2011
Price: $3500
Biobanks - 2011 Yearbook
GBI Research, the leading business intelligence provider, has released its latest research, Biobanks - 2011 Yearbook. It provides key data, information and analysis of the 40 major biobanks in the world. The report provides information on the population-based biobanks, disease based biobanks, brai
Published Date: Mar 2011
Price: $3500
Clinical Trial Endpoints in Oncology - Inclusion of Surrogate Endpoints and Shorter Endpoints Will Ensure Faster Clinical Trials in Oncology
GBI Research, the leading business intelligence provider, has released its latest research Clinical Trial Endpoints in Oncology Inclusion of Surrogate Endpoints and Shorter Endpoints will Ensure Faster Clinical Trials in Oncology, which essentially provides insights into clinical trial endpoints i
Published Date: Mar 2011
Price: $3500
Biosimilars Approval Pathways in the US and Europe - Development and Approval of Biosimilar mABs May Face Tough Regulatory Environment
GBI Research, the leading business intelligence provider, has released its latest report, Biosimilars Approval Pathways in the US and Europe Development and Approval of Biosimilar mAbs May Face Tough Regulatory Environment that provides key data, information and analysis of the major trends and is
Published Date: Apr 2011
Price: $3500
Cancer Supportive Care Products Market to 2016 - Market is Expected to Decline after 2014 Due to Generic Erosion and Entry of Biosimilars
GBI Research, the leading business intelligence provider, has released its latest research, Cancer Supportive Care Products Market to 2016 Market is Expected to Decline after 2014 Due to Generic Erosion and Entry of Biosimilars, which provides insights into the cancer supportive care products mark
Published Date: Apr 2011
Price: $3500
Orthobiologics Market to 2016 - Alternatives to Surgery and Superior Outcomes are Driving Wider Adoption of Orthobiologics
GBI Researchs new report, Orthobiologics Market to 2016 - Alternatives to Surgery and Superior Outcomes are Driving Wider Adoption of Orthobiologics provides key data, information and analysis on the Orthobiologics industry and analytical content on the market dynamics. The report provides mar
Published Date: Jun 2011
Price: $3500

 


 

Related News

Pernod Ricard Targets Premium over Prestige in China Market as ‘New normal’
In China, the international spirits category has begun a ‘new normal’, as stated by Pernod Ricard, with low priced offerings expected to drive growth in future. Since the anti-extravagance legislation came into effect in the country in q2012, international spirits companies such as Pernod witnessed plunging sales.  Subsequently, the drop in demand for high end spirits affected Pernod with 23% drop in sales in China in the financial year 2014. However, last week, the gro
Date: Sep 03

Alcohol Tax Revenue Outweighs Cost to Public Pocket in England
In England, the cost of alcohol use has been over stated by public health campaigners. On the contrary, the revenue from alcohol can touch as much as 6.5 billion GBP, as stated by Institute of Economic Affairs. According to the report, the cost of alcohol to government services such as police, health, welfare, and criminal justice comes out to be 3.9 billion GBP each year, On the other hand, the revenue from alcohol totals to be 10.4billion GBP. The people involved in public health campaig
Date: Sep 03

Healthcare Remote Monitoring Improves Obesity, Diabetes Care: Mayo Clinic
With the medical industry being characterized by reformative practices, using a wide range of the latest technologies, and revising its reimbursement policies in order to boost health outcomes and enhance patient care, the health care remote monitoring market is likely to have a huge influence on the growth as well as strength of the overall industry. New tools and devices such as mobile health technologies and biosensors could potentially strengthen and change the health care remote monitori
Date: Sep 03

Expanded Anti-Discrimination Law for US Healthcare Industry
The United States government proposed on Thursday the idea of a nondiscrimination law for the health care system in the country that clearly demands that medical providers as well as insurers to treat all patients without any bias, including transgender people.  Obamacare, or the Affordable Care Act, which was passed in 2010, comprises nondiscrimination provisions that deter insurers from denying insurance coverage based on sex or age or charge customers extra.  However, the law
Date: Sep 03

U.S. Oil Settles to $46.75 per Barrel, Up 1%
A loss was gain seen in crude futures after they rose more than 4 per cent on this Thursday as the equity market exhibited strong sales, the bad news out of China saw some respite and the potential for more monetary funds from Europe which added to risk taking in crude oil. But the positivity faded by the time afternoon trading had begun. By that time, the prices of oil had come down from the morning highs by the noon on Thursday, most likely owing to the prevailing weak market conditions for
Date: Sep 03

Chinese Rail Contractor Offers to Build High-Speed Railway in Sweden
A major rail contractor in China has, off the record, offered to build a planned high speed railway in Sweden for US$ 3 billion lesser and in five years fewer than what was initially estimated by the Sweden state transport administration. The contractor, China Railway Construction, made the confidential offer to the Sweden parliament’s Standing Committee for Transport. The document, however, was leaked to a national TV broadcaster of Sweden, SVT.  The offer by China claims to of
Date: Sep 02

Construction Spending in US Soars to Highest in 7 Years
Construction spending in the United States in the month of July jumped to a level that is the highest in over seven years, indicating that the business investment and the housing market can aid in underpinning economic development even amid turmoil beyond American boundaries.  The total construction spending rose by 0.7 per cent compared to the previous month to reach a seasonally adapted annual rate of US$ 1.083 trillion to mark the highest level since 2008 in May, according to the Comm
Date: Sep 02

Chinese E-commerce King Alibaba Seeking to Expand Latin America Presence
Alibaba, the e-commerce e giant in China is seeking ways to expand presence in Latin Amer4iac, as stated by Michael Lee, head of business development and international marketing at Alibaba. The expansion of the company is basically focused on Brazil and Argentina, wherein the company has been steadily growing in the last few years, the business head further added. The declaration was made by the business head recently in Buenos Aires at a conference organized by Argentina Chamber for Elect
Date: Sep 02

Global PMI Index Shows Further Contraction in China’s Manufacturing Sector
According to latest data, the manufacturing industry in China has further contracted while the euro zone and the U.S. growth eased in August. Keeping the recent developments of the world economy in view, the International Monetary Fund has lowered its forecast for world growth this year. Last month witnessed turbulence in Chinese economy affecting the stocks and the commodity prices on major markets.  The investors are wondering if the Federal Reserve would increase the interest rate in Sep
Date: Sep 02

NASA’s Developing Megawatt Solar Power Arrays for a Use with Solar Electric Propulsion
NASA Glenn Research Center, GRC, presently offers several programs to progress in the future photovoltaic array development. NASA Space Technology Program selected ATK- Alliant Technical Systems in 2012 for development of a neat solar array structure and lightweight structure, under a Game Changing Technology competition. The project proposes the design and manufacture of deployable solar arrays based on TRI 5 (technology readiness). The project is larger than the solar array blankets install
Date: Sep 02

Upcoming Reports

Hormone Replacement Therapy Market - Global Industry Size, Market Share, Trends, Analysis And Forecasts, 2012 - 2018
Hormone replacement therapy (HRT) is administration of hormones to those patients who are under a phase of declining natural hormones in their body. Hormone replacement therapy is mostly administered to women undergoing menopausal phase. The hormones which are administered to patients are most
Published By: Transparency
Price: $4795
Bio-Implants Market - Global Industry Analysis, Market Size, Market Share And Forecast, 2012 - 2018
Bio-implants are bioengineered products known to be of human or animal origin used in the different fields of ENT. Generally, these bio-implants are offered for safeguarding after tissue replacement. These bio-implants are made up of biosynthetic materials known as collagen or it can also be made
Published By: Transparency
Price: $4795
Biobanks Market - Global Industry Size, Market Share, Trends, Analysis And Forecast, 2012 - 2018
Biobanks is a collection or storation of blood and cell samples from a large number of people. Biobank collection denotes its use in medical field and research. The global biobank industry is segmented into different sectors such as human tissue banking, or population banking, stem cell banking, c
Published By: Transparency
Price: $4795
Orthobiological Products Market - Global Industry Analysis, Market Size, Market Share And Forecasts, 2012 - 2018
The global orthobiological products market is expected to grow to $15.3 billion by the year 2022 as a result of tremendous growth in the medical devices industry mainly due to increase in aging population. Growth of orthobiological products is driven by increasing awareness towards adoption of ort
Published By: Transparency
Price: $4795
Gene Amplification Technologies Market - Global Industry Analysis, Market Size, Market Share And Forecasts, 2012 - 2018
Gene amplification technology is proving to be an important technology in human genome projects and other important fields like diagnostics. There are number of companies involved in the business of gene amplification and diagnostics with over 30 gene and signal amplification technologies. These g
Published By: Transparency
Price: $4795
DNA Sequencing Market - Global Industry Analysis, Market Size, Market Share And Forecasts, 2012 - 2018
The global DNA sequencing market is forecast to grow to $6.6 billion over the year 2016 at the compounded annual growth rate of 17.5% as a result of emerging technologies in this field and its use in a number of applications.   DNA sequencing industry is segmented into instruments and consu
Published By: Transparency
Price: $4795
Epigenetics Market - Global Industry Analysis, Market Size, Market Share And Forecasts, 2012 - 2018
The global epigenetics market is projected to reach the value of $18.2 billion by the year 2015 driven by investigation of factors influencing cellular malfunction and disease development. Also, developments in epigenetic studies like biomarker discovery and scientifically useful biomarker tests a
Published By: Transparency
Price: $4795
Biologics Market - G7 Industry Size, Market Share, Trends, Analysis, And Forecasts 2012 - 2018
With an increase in the number of clinical trials in the past 5 years, the market for biologics is expected to witness a high growth during the coming years. Monoclonal antibodies, vaccines and therapeutic proteins will contribute significantly to the growth in the biologics market. The global
Published By: Transparency
Price: $4795
Biosimilar and Follow-On Biologics Market - Global Industry Size, Market Share, Trends, Analysis And Forecasts 2012 - 2018
There is a rising demand for low cost biological drugs. Commercial and regulatory developments are taking the follow-on biologics market to new heights. Drug manufacturers are exploring the possibilities of producing generic biopharmaceuticals drugs with a motive of reducing the prices of thes
Published By: Transparency
Price: $4795
Biopesticides Market - Global Industry Analysis, Market Size, Market Share And Forecasts, 2012 - 2018
Biopesticides are essential for controlling the effect of agricultural pests, insects, and bacterial and fungal growth on food and field crops. Use of biopesticides can avoid the hazards caused by the use of chemical pesticides on the environment. Growing environmental concerns and stringent r
Published By: Transparency
Price: $4795